Hemiparesis/Hemiplegia (One Sided Weakness/Paralysis)NCT05138185
Proof-of-concept of a Robotic Knee Exoskeleton in Healthy Subjects and Hemiparetic Patients During Gait.
A study testing Exoskeleton assisted gait on a treadmill in people with Hemiparesis/Hemiplegia (One Sided Weakness/Paralysis), run by Spanish National Research Council at 1 site in Spain.
Trial summary
Hemiparetic gait is characterized by strong asymmetries that could severely affect the quality of life of stroke survivors. This asymmetry is due to motor deficits in the paretic leg and the resulting compensations in the non-paretic limb. Read more about this study
- Who is it for?
- Ages 18 to 85 yearsHealthy volunteers can take part
- Conditions the study is for
- Hemiparesis/Hemiplegia (One Sided Weakness/Paralysis)
- What is being tested?
- Exoskeleton assisted gait on a treadmill
- Type of treatment
- Medical device
- How many people
- 3 participants
- Where
- 1 siteSpain
- Study dates
- 15 Feb 2021to 20 Apr 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 85 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
None listed.
Who cannot join
- Acute musculoskeletal diseases
- Peripheral vascular diseases
- Acute cardiopulmonary diseases
- Acute neurological diseases
- Excessive spasticity in any joint of the lower limb (Ashworth scale> 2)
- Joint mobility restriction of lower limb joints due to any cause
- Pain due to impaired mobility of the lower limb
- Inability to use robotic exoskeleton prototypes due to his/her health condition.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Evaluation of the Effects of the Unilateral Assistance Provided by a Robotic Knee Exoskeleton in the Gait Symmetry of Healthy Subjects and Hemiparetic Patients.
Hemiparetic gait is characterized by strong asymmetries that could severely affect the quality of life of stroke survivors. This asymmetry is due to motor deficits in the paretic leg and the resulting compensations in the non-paretic limb.
In this study, the investigators aim to evaluate the effect of actively promoting gait symmetry in hemiparetic patients by assessing the behavior of both paretic and non-paretic lower limbs. To this end, the investigators use a unilateral active Knee-Ankle-Foot Orthosis able to assist the paretic limb of hemiparetic patients during gait.
Read more
The system is able to synchronize its action with the movement of the unassisted joints, promoting a natural and intuitive interaction. The device generate the assistance according to two differents strategies: (1) Replicating the movement of the helathy leg or (2) Inducing a healthy gait pattern on the paretic leg.
The hypothesis is that a proper and natural interaction between the user and the exoskeleton would enable the patients to consider the robot action as a part of their own gait capability, improving their gait quality as consequence. Hemiparetic asymmetry is not only due to impairments in the affected limb, but also it is the consequence of biomechanical compensatory mechanisms that might arose in the non-paretic leg. We aim to assess the adaptation process of the subject to the exoskeleton assistance, and to evaluate the effects of such human-robot interaction in both paretic and non-paretic legs.
Read the detailed description
- Brief name: Proof-of-concept of a unilateral robotic knee exoskeleton and evaluation of its effects over gait symmetry.
- Materials: The investigators have developed a Knee-Ankle-Foot orthosis (KAFO) composed of two joints aligned to the knee and ankle of the user. The length of its bars and the positions of its braces can be tailored to the anthropometry of different users. The knee joint is actuated by a DC brushless motor EC-60 flat 408057 (Maxon ag, Switzerland) coupled with a harmonic drive CSD-20-160-2AGR (Harmonic Drive LLC, EE.UU.). The transmission ratio of 1:60 of this system enables the application of a mean torque of 35Nm. The ankle joint of the prototype remains non-actuated and unlimited, enabling its free movement in the sagittal plane. The total weight of the KAFO is about 4kg.
The prototype is equipped with sensors that provide information on system variables that are used for its control in real-time, such as the flexion angle of the robot joint or the interaction torque between user and robot. In addition, the gait kinematic of the user is measured by Inertial Measurement Units (IMUs) and the contact of both feet with the floor by Force Sensing Resistors (FSRs).
The system uses an Adaptive Frequency Oscillator to estimate the continuous gait phase of the contralateral limb and synchronically assists the paretic leg following two different control strategies: (1) Replicating the movement of the sound leg (Echo Strategy) or (2) Inducing a healthy gait pattern on the paretic leg (Pattern strategy). The action of the robot depends on the gait phase of the assisted leg: during stance the robot reinforces the limb so the system composed of the leg and the exoskeleton can load the user's weight and not collapse, while during the swing phase the robot guides the limb's movement according to the Assisted-As-Needed (AAN) paradigm creating a force tunnel around the prescribed trajectory.
- Procedures: Subjects were instructed to walk on a treadmill at a constant speed during trials of 5 minutes. All subjects carried out four different kinds of trials: (1) NoExo: subjects only wore the inertial sensors and the insole pressure sensors to acquire their basal motion; (2) Free: subjects wore the exoskeleton although the actuator was mechanically decoupled, so it enabled the free movement of the knee; (3) Echo: the device provided gait assistance following the Echo-control strategy; and (4) Pattern: the device provided gait assistance following the Pattern strategy. During trials, patients wore a safety harness, although it did not support any weight. Previously to the execution of the trials, the gait velocity was self-selected by the subjects to a comfortable level. Subjects rested between trials for five minutes at least, in order to avoid adaptation and learning effects from trial to trial.
Healthy subjects also performed a previous trial under variable gait speed (VariableSpeed). They walked over the treadmill as in the NoExo condition, although the gait speed randomly varies from 1km/h to 3km/h in 0.2km/h steps for 15 seconds at least.
- Intervention providers A physiotherapist and an engineer are present during the trials. The first is responsible of assessing the basal gait of the subjects and evaluating his/her state while the assistance is provided. The engineer is responsible of managing the device and recording the data.
Both researchers monitor fidelity to the intervention by direct supervision.
- Modes of delivery The protocol is provided to one participant at a time. Each patient completes the protocol once.
- Location Hospital Beata María Ana (Madrid, Spain)
- Tailoring and modifications The protocol remains unaltered across applications. The only adaptation to patients is the choice of the comfortable gait speed for the trials.
- Being tested
- Exoskeleton assisted gait on a treadmill
- Keywords
- Hemiparetic Gait, Robotic Knee Exoskeleton
- Medical subject headings
- Paresis, Hemiplegia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Exoskeleton assisted gait on a treadmillDevice
Subjects were instructed to walk on a treadmill at a constant speed during trials of 5 minutes. All subjects carried out four trials: (1) NoExo: subjects only wore the sensors to acquire their basal motion; (2) Free: subjects wore the exoskeleton although the actuator was mechanically decoupled, so it enabled the free movement of the knee; (3) Echo: the device provided gait assistance following the Echo-control strategy; and (4) Pattern: the device provided gait assistance following the Pattern strategy. During trials, patients wore a safety harness that did not support any weight. Previously to the execution of the trials, the gait velocity was self-selected by the subjects to a comfortable level. Subjects rested between trials for five minutes. Healthy subjects also performed a previous trial under variable gait speed. They walked over the treadmill as in the NoExo condition, although the gait speed randomly varies from 1km/h to 3km/h in 0.2km/h steps for 15 seconds at least.
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility of the prototype device
The joints motion is measured by Inertial Sensors
Measured: During the last two minutes of the intervention
Secondary outcomes (2)
Symmetry of step length from thigh and shank kinematics
The joint motion is measured by Inertial Sensors
Measured: During the last two minutes of the intervention
Symmetry of step time
Data is collected from floor contact events detected by FSRs
Measured: During the last two minutes of the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Nov 2021
- Study start15 Feb 2021
- Primary completion20 Apr 2021
- Study completion20 Apr 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hemiparesis/Hemiplegia (One Sided Weakness/Paralysis)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Device feasibility
- Allocation
- Not applicable
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 3 participants (actual)
Sponsor and investigators
- Lead sponsor
- Spanish National Research Council
- Sponsor type
- Other government
- Collaborators
- Hospital Beata María Ana
- Responsible party
- Principal investigator, Julio S. Lora Millan, Spanish National Research Council
- Investigators
- Julio S. Lora-Millan, Principal investigator, Spanish National Research Council
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05138185
- Sponsor's protocol ID
- REFLEX_TechValidation
- Status last verified
- Nov 2021
- First submitted
- 23 Oct 2021
- Last updated
- 30 Nov 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
Study at a glance
From the registry record, last updated by the sponsor on 30 Nov 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Effects of the Unilateral Assistance Provided by a Robotic Knee Exoskeleton in the Gait Symmetry of Healthy Subjects and Hemiparetic Patients.
- ClinicalTrials.gov ID
- NCT05138185
- Acronym / sponsor ID
- REFLEX_TechValidation
- Keywords
- Hemiparetic Gait, Robotic Knee Exoskeleton
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 3 participants (actual)
- Lead sponsor
- Spanish National Research CouncilOther government
- Collaborators
- Hospital Beata María Ana
- Study start
- 15 Feb 2021 (actual)
- Primary completion
- 20 Apr 2021 (actual)
- Study completion
- 20 Apr 2021 (actual)
- First posted
- 30 Nov 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hemiparetic gait is characterized by strong asymmetries that could severely affect the quality of life of stroke survivors. This asymmetry is due to motor deficits in the paretic leg and the resulting compensations in the non-paretic limb.
In this study, the investigators aim to evaluate the effect of actively promoting gait symmetry in hemiparetic patients by assessing the behavior of both paretic and non-paretic lower limbs. To this end, the investigators use a unilateral active Knee-Ankle-Foot Orthosis able to assist the paretic limb of hemiparetic patients during gait.
The system is able to synchronize its action with the movement of the unassisted joints, promoting a natural and intuitive interaction. The device generate the assistance according to two differents strategies: (1) Replicating the movement of the helathy leg or (2) Inducing a healthy gait pattern on the paretic leg.
The hypothesis is that a proper and natural interaction between the user and the exoskeleton would enable the patients to consider the robot action as a part of their own gait capability, improving their gait quality as consequence. Hemiparetic asymmetry is not only due to impairments in the affected limb, but also it is the consequence of biomechanical compensatory mechanisms that might arose in the non-paretic leg. We aim to assess the adaptation process of the subject to the exoskeleton assistance, and to evaluate the effects of such human-robot interaction in both paretic and non-paretic legs.
Detailed description
- Brief name: Proof-of-concept of a unilateral robotic knee exoskeleton and evaluation of its effects over gait symmetry.
- Materials: The investigators have developed a Knee-Ankle-Foot orthosis (KAFO) composed of two joints aligned to the knee and ankle of the user. The length of its bars and the positions of its braces can be tailored to the anthropometry of different users. The knee joint is actuated by a DC brushless motor EC-60 flat 408057 (Maxon ag, Switzerland) coupled with a harmonic drive CSD-20-160-2AGR (Harmonic Drive LLC, EE.UU.). The transmission ratio of 1:60 of this system enables the application of a mean torque of 35Nm. The ankle joint of the prototype remains non-actuated and unlimited, enabling its free movement in the sagittal plane. The total weight of the KAFO is about 4kg.
The prototype is equipped with sensors that provide information on system variables that are used for its control in real-time, such as the flexion angle of the robot joint or the interaction torque between user and robot. In addition, the gait kinematic of the user is measured by Inertial Measurement Units (IMUs) and the contact of both feet with the floor by Force Sensing Resistors (FSRs).
The system uses an Adaptive Frequency Oscillator to estimate the continuous gait phase of the contralateral limb and synchronically assists the paretic leg following two different control strategies: (1) Replicating the movement of the sound leg (Echo Strategy) or (2) Inducing a healthy gait pattern on the paretic leg (Pattern strategy). The action of the robot depends on the gait phase of the assisted leg: during stance the robot reinforces the limb so the system composed of the leg and the exoskeleton can load the user's weight and not collapse, while during the swing phase the robot guides the limb's movement according to the Assisted-As-Needed (AAN) paradigm creating a force tunnel around the prescribed trajectory.
- Procedures: Subjects were instructed to walk on a treadmill at a constant speed during trials of 5 minutes. All subjects carried out four different kinds of trials: (1) NoExo: subjects only wore the inertial sensors and the insole pressure sensors to acquire their basal motion; (2) Free: subjects wore the exoskeleton although the actuator was mechanically decoupled, so it enabled the free movement of the knee; (3) Echo: the device provided gait assistance following the Echo-control strategy; and (4) Pattern: the device provided gait assistance following the Pattern strategy. During trials, patients wore a safety harness, although it did not support any weight. Previously to the execution of the trials, the gait velocity was self-selected by the subjects to a comfortable level. Subjects rested between trials for five minutes at least, in order to avoid adaptation and learning effects from trial to trial.
Healthy subjects also performed a previous trial under variable gait speed (VariableSpeed). They walked over the treadmill as in the NoExo condition, although the gait speed randomly varies from 1km/h to 3km/h in 0.2km/h steps for 15 seconds at least.
- Intervention providers A physiotherapist and an engineer are present during the trials. The first is responsible of assessing the basal gait of the subjects and evaluating his/her state while the assistance is provided. The engineer is responsible of managing the device and recording the data.
Both researchers monitor fidelity to the intervention by direct supervision.
- Modes of delivery The protocol is provided to one participant at a time. Each patient completes the protocol once.
- Location Hospital Beata María Ana (Madrid, Spain)
- Tailoring and modifications The protocol remains unaltered across applications. The only adaptation to patients is the choice of the comfortable gait speed for the trials.
Study design
- Primary purpose
- Device feasibility
- Allocation
- Not applicable
- Intervention model
- Crossover
- Masking
- None (open label)
Who may qualify
- Ages
- 18 to 85 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (0 listed)
Key exclusion criteria (8 listed)
- Acute musculoskeletal diseases
- Peripheral vascular diseases
- Acute cardiopulmonary diseases
- Acute neurological diseases
- Excessive spasticity in any joint of the lower limb (Ashworth scale> 2)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Exoskeleton assisted gait on a treadmillSubjects were instructed to walk on a treadmill at a constant speed during trials of 5 minutes. All subjects carried out four trials: (1) NoExo: subjects only wore the sensors to acquire their basal motion; (2) Free: subjects wore the exoskeleton although the actuator was mechanically decoupled, so it enabled the free movement of the knee; (3) Echo: the device provided gait assistance following the Echo-control strategy; and (4) Pattern: the device provided gait assistance following the Pattern strategy. During trials, patients wore a safety harness that did not support any weight. Previously to the execution of the trials, the gait velocity was self-selected by the subjects to a comfortable level. Subjects rested between trials for five minutes. Healthy subjects also performed a previous trial under variable gait speed. They walked over the treadmill as in the NoExo condition, although the gait speed randomly varies from 1km/h to 3km/h in 0.2km/h steps for 15 seconds at least. | Device | – |
Primary outcome
Feasibility of the prototype device
Time frame: During the last two minutes of the intervention
The joints motion is measured by Inertial Sensors
2 secondary outcomes
Symmetry of step length from thigh and shank kinematics
Time frame: During the last two minutes of the intervention
Symmetry of step time
Time frame: During the last two minutes of the intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Nov 2021.
- Individual participant dataSharing planned: Yes. The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
Related trials for Hemiparesis/Hemiplegia (One Sided Weakness/Paralysis)
Recruiting
Effects of Atalante Exoskeleton on Gait Recovery in Non- or Poorly Ambulatory Patients With Hemiparesis in the Acute/Subacute Phase (Month 1 to 4)
Stroke, Acute, Stroke, Ischemic
Recruiting
Isokinetic Strength Training in Hemiparetic Patient With Knee Extension Thrust
Hemiparesis/Hemiplegia (One Sided Weakness/Paralysis), Gait Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Julio S. Lora-Millan principal investigator
Spanish National Research Council
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exoskeleton assisted gait on a treadmill in people with Hemiparesis/Hemiplegia (One Sided Weakness/Paralysis), run by Spanish National Research Council at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 0 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility of the prototype device (time frame: During the last two minutes of the intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2021.